Nuclear morphology predicts cell survival to cisplatin chemotherapy

The emergence of chemotherapy resistance drives cancer lethality in cancer patients, with treatment initially reducing overall tumor burden followed by resistant recurrent disease. While molecular mechanisms underlying resistance phenotypes have been explored, less is known about the cell biological...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Chi-Ju, Gonye, Anna LK, Truskowski, Kevin, Lee, Cheng-Fan, Cho, Yoon-Kyoung, Austin, Robert H., Pienta, Kenneth J., Amend, Sarah R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314150/
https://www.ncbi.nlm.nih.gov/pubmed/37172462
http://dx.doi.org/10.1016/j.neo.2023.100906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314150/
https://www.ncbi.nlm.nih.gov/pubmed/37172462
http://dx.doi.org/10.1016/j.neo.2023.100906

Ejemplares similares